Sort   by:  
 Page size 
GenomicsHuman single nuclear RNA sequencing identifies CD47 as a therapeutic target for doxorubicin-induced cardiomyopathy
Human single nuclear RNA sequencing identifies CD47 as a therapeutic target for doxorubicin-induced cardiomyopathy
PRJNA1236641 | ENA
UnknownExploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis.
Not available
S-EPMC5467270 | biostudies-literature
UnknownHypoxic preconditioning promotes recipient monocyte adaptation to improve heart transplant outcomes
Not available
S-SCDT-10_1038-S44321-026-00543-0 | biostudies-other
UnknownBurden of breast cancer and attributable risk factors in the North Africa and Middle East region, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
Not available
S-EPMC10431599 | biostudies-literature
UnknownFostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia: A Randomized Clinical Trial.
Not available
S-EPMC11615712 | biostudies-literature
UnknownBurden of disease scenarios by state in the USA, 2022-50: a forecasting analysis for the Global Burden of Disease Study 2021.
Not available
S-EPMC11715278 | biostudies-literature
UnknownGlobal mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
Not available
S-EPMC9763654 | biostudies-literature
UnknownAdolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019.
Not available
S-EPMC9329128 | biostudies-literature
UnknownRenin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials.
Not available
S-EPMC10091180 | biostudies-literature
UnknownBurden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.
Not available
S-EPMC11121021 | biostudies-literature
Sort   by:  
 Page size